INTRODUCTION: The COVID pandemic has had a high psychological impact on healthy populations. Increased levels of perceived stress, depression, and insomnia are expected, especially in people with pre-existing medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD), who seem to be particularly vulnerable. However, the difference in psychological distress frequency between asthma and COPD patients is unknown. OBJECTIVE: To compare the prevalence of depression, perceived stress related to COVID, post-traumatic stress, and insomnia in asthma and COPD patients at a pulmonology clinic in Santa Marta, Colombia. METHODS: A cross-sectional study was designed. The patients were contacted by telephone. An electronic link was sent to those who accepted. The questionnaire asked for perceived stress related to COVID-19, post-traumatic stress symptoms, depressive symptoms, and insomnia risk. RESULTS: 148 asthma patients and 144 COPD patients participated in, between 18 and 96 years. The prevalence of high COVID-19 perceived stress was 10.6% (n = 31); post-traumatic stress risk, 11.3% (n = 33); depression risk, 31.5% (n = 92); and insomnia risk, 57.7% (n = 169). No significant differences were found between asthma and COPD in indicators of psychological distress. CONCLUSIONS: Asthma and COPD patients present similar frequencies of depression risk, COVID-19 perceived stress, post-traumatic stress risk, and insomnia risk during the Colombian lockdown. It is essential to evaluate and manage psychological distress among asthma and COPD patients. It can reduce the risk of exacerbation and improve the quality of life.
INTRODUCTION: The COVID pandemic has had a high psychological impact on healthy populations. Increased levels of perceived stress, depression, and insomnia are expected, especially in people with pre-existing medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD), who seem to be particularly vulnerable. However, the difference in psychological distress frequency between asthma and COPDpatients is unknown. OBJECTIVE: To compare the prevalence of depression, perceived stress related to COVID, post-traumatic stress, and insomnia in asthma and COPDpatients at a pulmonology clinic in Santa Marta, Colombia. METHODS: A cross-sectional study was designed. The patients were contacted by telephone. An electronic link was sent to those who accepted. The questionnaire asked for perceived stress related to COVID-19, post-traumatic stress symptoms, depressive symptoms, and insomnia risk. RESULTS: 148 asthmapatients and 144 COPDpatients participated in, between 18 and 96 years. The prevalence of high COVID-19 perceived stress was 10.6% (n = 31); post-traumatic stress risk, 11.3% (n = 33); depression risk, 31.5% (n = 92); and insomnia risk, 57.7% (n = 169). No significant differences were found between asthma and COPD in indicators of psychological distress. CONCLUSIONS:Asthma and COPDpatients present similar frequencies of depression risk, COVID-19 perceived stress, post-traumatic stress risk, and insomnia risk during the Colombian lockdown. It is essential to evaluate and manage psychological distress among asthma and COPDpatients. It can reduce the risk of exacerbation and improve the quality of life.
The COVID pandemic has had a high psychological impact on healthy populations; it has increased the reporting of depression, perceived stress, post-traumatic stress, and insomnia.[1] Increased levels of perceived stress, depression, and insomnia are expected, especially in people with pre-existing medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD), who seem to be particularly vulnerable.[2] The COVID pandemic configures a significant stressor due to the changes associated with confinement, stay at home, physical distancing, and daily routine changes. Stressors can increase the risk of exacerbation and fatal outcome in people with pulmonary morbidity.[3] It was hypothesized that COPDpatients would present more considerable psychological distress than asthmapatients based on disease features.[4]The study aimed to compare the prevalence of depression, perceived stress related to COVID, post-traumatic stress, and insomnia in asthma and COPDpatients at a pulmonology clinic in Santa Marta, Colombia.
Methods
A cross-sectional study was designed; it was approved by the Research Ethics Committee of the University of Magdalena, Santa Marta, Colombia (Act 002 of March 26th, 2020). Asthma and COPD adult outpatients gave informed consent and participated in the study, as stipulated in the Declaration of Helsinki.The patients were contacted by telephone. An electronic link was sent to those who accepted. The questionnaire asked for demographic information and completed four scales: Perceived Stress Related to COVID-19 (α = 0.87), cut-off point 25 for high perceived stress[5]; Brief Davidson Trauma Scale (α = 0.81), cut-off point 12 for post-traumatic stress risk[6]; Patient Health Questionnaire, PHQ-9 (α = 0.87), cut-off point 7 for depression risk[7]; and Athens Insomnia Scale (α = 0.84), cut-off point 6, insomnia risk.[8] Crude odds ratios (OR) were calculated, and after ORs were adjusted for age and gender.
Results
Three hundred seven patients was contacted, and 227 (90.2%) accepted to participate in, 148 asthmapatients and 144 COPDpatients. The ages were between 18 and 96 years (M = 60.4, SD = 17.6); COPDpatients were significantly older than asthmapatients (M = 70.8, SD = 11.4 versus M = 50.4, SD = 16.7; t = 12.2, df = 290, p < 0.001). By gender, 189 women (64.7%) and 139 men (35.3%); the female group was over-represented in the asthma group (71.6% versus 57.6%, p = 0.01). The prevalence of high COVID-19 perceived stress was 10.6% (n = 31); post-traumatic stress risk, 11.3% (n = 33); depression risk, 31.5% (n = 92); and insomnia risk, 57.7% (n = 169). See Table 1 presents no significant differences between asthma and COPD in indicator of psychological distress.
Table 1.
Comparison of psychological distress indicators between asthma and COPD patients.
Variable
COPD
Asthma
OR (95%CI)
n (%)
n (%)
Crude
Adjusteda
Depression risk
39 (28.5)
46 (32.9)
0.81 (0.49–1.36)
0.81 (0.44–1.48)
High perceived stressb
12 (8.8)
16 (14.4)
0.74 (0.34–1.64)
1.00 (0.39–2.55)
Post-traumatic stress risk
14 (10.2)
15 (10.7)
0.95 (0.44–2.05)
0.92 (0.37–2.26)
Insomnia risk
71 (51.8)
85 (60.7)
0.70 (0.43–1.12)
0.96 (0.54–1.71)
a Adjusted by age and gender.
b Related to COVID.
Comparison of psychological distress indicators between asthma and COPDpatients.a Adjusted by age and gender.b Related to COVID.
Discussion and conclusion
The present analysis was observed a similar frequency of high COVID-19 perceived stress, post-traumatic stress risk, depression risk, and insomnia risk among asthma and COPDpatients during the Colombian COVID lockdown. This finding is comparable to a previous study before the COVID pandemic; it was observed that scores for psychological distress were similar among asthma and COPDpatients.[9] Conversely, other researchers reported that COPDpatients reporting frequent mental distress because it was related to more common physical distress, disability, limitations, or requiring special equipment.[4] It is essential to evaluate and manage psychological distress among asthma and COPDpatients. It can reduce the risk of exacerbation and improve the quality of life.[10]This research compares patients with COPD and asthma of the frequency of some psychological distress indicators during the Colombian lockdown; nevertheless, there are some limitations. First, COPD and asthmapatients had no control group from the general population. Second, the results cannot be generalized due to the sampling strategy.In conclusion, asthma and COPDpatients present similar frequencies of depression risk, COVID-19 perceived stress, post-traumatic stress risk, and insomnia risk during the Colombian lockdown.
Authors: Roy A Pleasants; Jill A Ohar; Janet B Croft; Yong Liu; Monica Kraft; David M Mannino; James F Donohue; Harry L Herrick Journal: COPD Date: 2013-10-23 Impact factor: 2.409
Authors: Ivy Lynn Mak; Eric Yuk Fai Wan; Teenie Kwan Tung Wong; Wendy Woo Jung Lee; Esther Wai Yin Chan; Edmond Pui Hang Choi; Celine Sze Ling Chui; Mary Sau Man Ip; Wallace Chak Sing Lau; Kui Kai Lau; Shing Fung Lee; Ian Chi Kei Wong; Esther Yee Tak Yu; Cindy Lo Kuen Lam Journal: Public Health Rev Date: 2022-04-27
Authors: Haitham A Jahrami; Omar A Alhaj; Ali M Humood; Ahmad F Alenezi; Feten Fekih-Romdhane; Maha M AlRasheed; Zahra Q Saif; Nicola Luigi Bragazzi; Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Michael V Vitiello Journal: Sleep Med Rev Date: 2022-01-22 Impact factor: 11.401
Authors: Muhammad Omair Husain; Imran B Chaudhry; Amy Blakemore; Suleman Shakoor; Muhammad Ali Husain; Steven Lane; Tayyeba Kiran; Farhat Jafri; Rakhshi Memon; Maria Panagioti; Nusrat Husain Journal: SAGE Open Med Date: 2021-10-07
Authors: Zainab Alimoradi; Anders Broström; Hector W H Tsang; Mark D Griffiths; Shahab Haghayegh; Maurice M Ohayon; Chung-Ying Lin; Amir H Pakpour Journal: EClinicalMedicine Date: 2021-06-10